These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3196490)

  • 1. Spectrum of HIV-1 neutralizing antibodies in a cohort of homosexual men: results of a 6 year prospective study.
    Robert-Guroff M; Goedert JJ; Naugle CJ; Jennings AM; Blattner WA; Gallo RC
    AIDS Res Hum Retroviruses; 1988 Oct; 4(5):343-50. PubMed ID: 3196490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus neutralizing antibodies at different stages of the HIV disease: increased levels after azidothymidine treatment.
    Schmidtmayerová H; Lackovicová M; Stanková M; Brůcková M; Surový I; Ujhelyi E; Füst G; Mayer V
    Acta Virol; 1992 Mar; 36(2):157-65. PubMed ID: 1359767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial determinations of HIV-1 titers in HIV-infected homosexual men: association of rising titers with CD4 T cell depletion and progression to AIDS.
    Nicholson JK; Spira TJ; Aloisio CH; Jones BM; Kennedy MS; Holman RC; McDougal JS
    AIDS Res Hum Retroviruses; 1989 Apr; 5(2):205-15. PubMed ID: 2523717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV neutralizing antibodies: development and association with HIV related disease.
    Arendrup M; Ulrich K; Nielsen JO; Lindhardt BO; Kusk P; Mathiesen LR; Pedersen C; Krogsgaard K
    Scand J Infect Dis; 1989; 21(1):19-26. PubMed ID: 2727625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibodies as a prognostic indicator in the progression of acquired immune deficiency syndrome (AIDS)-related disorders: a double-blind study.
    Sei Y; Tsang PH; Roboz JP; Sarin PS; Wallace JI; Bekesi JG
    J Clin Immunol; 1988 Nov; 8(6):464-72. PubMed ID: 3146584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low antigenicity of HIV-1 rev: rev-specific antibody response of limited value as correlate of rev gene expression and disease progression.
    Reiss P; De Ronde A; Lange JM; De Wolf F; Dekker J; Danner SA; Debouck C; Goudsmit J
    AIDS Res Hum Retroviruses; 1989 Dec; 5(6):621-8. PubMed ID: 2692659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.
    Böttiger B; Ljunggren K; Karlsson A; Krohn K; Fenyö EM; Jondal M; Biberfeld G
    Clin Exp Immunol; 1988 Sep; 73(3):339-42. PubMed ID: 3208445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.
    Moog C; Fleury HJ; Pellegrin I; Kirn A; Aubertin AM
    J Virol; 1997 May; 71(5):3734-41. PubMed ID: 9094648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men.
    Margalith M; Sarov B; Sarov I; Rinaldo C; Detels R; Phair J; Kaslow R; Ginsberg H; Saah A
    AIDS Res Hum Retroviruses; 1990 May; 6(5):607-16. PubMed ID: 2193673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.
    Imagawa DT; Lee MH; Wolinsky SM; Sano K; Morales F; Kwok S; Sninsky JJ; Nishanian PG; Giorgi J; Fahey JL
    N Engl J Med; 1989 Jun; 320(22):1458-62. PubMed ID: 2716797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
    Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
    J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.
    Reiss P; Lange JM; de Ronde A; de Wolf F; Dekker J; Debouck C; Goudsmit J
    J Med Virol; 1990 Mar; 30(3):163-8. PubMed ID: 2341832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men.
    Polk BF; Fox R; Brookmeyer R; Kanchanaraksa S; Kaslow R; Visscher B; Rinaldo C; Phair J
    N Engl J Med; 1987 Jan; 316(2):61-6. PubMed ID: 3024007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression.
    Baum LL; Cassutt KJ; Knigge K; Khattri R; Margolick J; Rinaldo C; Kleeberger CA; Nishanian P; Henrard DR; Phair J
    J Immunol; 1996 Sep; 157(5):2168-73. PubMed ID: 8757343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of predictors of disease progression in relation to the development of AIDS.
    de Wolf F; Lange JM; Houweling JT; Mulder JW; Beemster J; Schellekens PT; Coutinho RA; van der Noordaa J; Goudsmit J
    AIDS; 1989 Sep; 3(9):563-9. PubMed ID: 2571348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual practices and condom usage in a cohort of homosexual men in relation to human immunodeficiency virus status.
    Tindall B; Swanson C; Donovan B; Cooper DA
    Med J Aust; 1989 Sep; 151(6):318-22. PubMed ID: 2593942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of immunoglobulin changes in relation to human immunodeficiency virus infection in a cohort of homosexual men.
    Bratt G; Waldenlind L; Von Krogh G; Karlsson A; Moberg L; Biberfeld G; Sandström E
    Scand J Immunol; 1989 May; 29(5):589-95. PubMed ID: 2727623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group.
    Hengel RL; Kennedy MS; Steketee RW; Thea DM; Abrams EJ; Lambert G; McDougal JS
    AIDS Res Hum Retroviruses; 1998 Apr; 14(6):475-81. PubMed ID: 9566549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men: a report from the Multicenter AIDS Cohort Study.
    Dis Markers; 1989; 7(4):257-8. PubMed ID: 2684476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.